Cardiol Therapeutics Inc. (TSE:CRDL – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as C$1.41 and last traded at C$1.42, with a volume of 64429 shares trading hands. The stock had previously closed at C$1.52.
Cardiol Therapeutics Stock Performance
The company has a current ratio of 2.49, a quick ratio of 6.84 and a debt-to-equity ratio of 1.59. The company has a market cap of C$114.51 million, a PE ratio of -2.71 and a beta of 0.70. The firm’s fifty day moving average is C$1.76 and its 200 day moving average is C$2.17.
Cardiol Therapeutics Company Profile
Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis.
Recommended Stories
- Five stocks we like better than Cardiol Therapeutics
- What Are Dividends? Buy the Best Dividend Stocks
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Low PE Growth Stocks: Unlocking Investment Opportunities
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- What is a Special Dividend?
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
